New information released by GlobalData showed that there are now more than 718 pipeline drugs associated with COVID-19.
According to the World Health Organization and ClinicalTrials.gov, there are 1,114 ongoing clinical studies of treatments for COVID-19. A GlobalData analysis indicates that 21 of the trials have reported interim results, with 16 showing positive early results.
Expectations that a vaccine against COVID-19 will be available within a year’s time are mixed, based on recent surveys conducted by BioSpace, as well as the analytics company GlobalData.
Top 200 Medicines Annual Report 2018: Blockbusters thriving despite tumultuous climate
Analysts, Analytics, Approvals, August 2018, Biologics, Biosimilars, Blockbusters, Business, Cannabinoids, Dravet syndrome, Epilepsy, EvaluatePharma, FDA/Regulatory, Gastroenterology, GlobalData, Immunological Disorders, Immunology, Immunomodulator Drugs, Innovation, Issue Archives, Lennox-Gastaut Syndrome (LGS), Mantle Cell Lymphoma (MCL), Myelodysplastic Syndromes, Prostate Cancer, Shingles, Special Reports, Therapeutics, Top 200 Medicines, Tumor Necrosis Factor (TNF) Inhibitors, Ulcerative ColitisThere were as many billion-dollar brands in 2017 as there have been in any other calendar year despite the cratering effects of massive patent cliffs in 2012 and 2015.